Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

New York Presbyterian Hospital, New York

Long Island Clinical Research Associates, Great Neck

University of Rochester, Rochester

Mid-Atlantic Medical Research Center, Hollywood

Metropolitan Gastroenterology Group P.C., Chevy Chase

University of Virginia Health System, Charlottesville

University of North Carolina at Chapel Hill, Chapel Hill

Charlotte Gastroenterology and Hepatology P.L.L.C, Charlotte

Consultants in Gastroenterology, Columbia

Atlanta Gastroenterology Specialist PC, Suwanee

Atlanta Gastroenterology Associates, Atlanta

Gastroenterology Associates of Central Georgia, Macon

University of Florida, Gainesville

Shafran Gastroenterology Center, Winter Park

University of Miami Miller School of Medicine, Miami

Gastroenterology Center of the MidSouth PC, Germantown

University Of Louisville, Louisville

University of Kentucky Medical Center, Lexington

Consultants for Clinical Research Inc., Cincinnati

Center for Digestive Health, Troy

University of Michigan, Ann Arbor

Huron Gastroenterology Associates, Ypsilanti

Wisconsin Center for Advanced Research, Milwaukee

Medical College Of Wisconsin, Milwaukee

Minnesota Gastroenterology P.A., Plymouth

Mayo Clinic, Rochester

University of Chicago Medical Center, Chicago

Washington University, St Louis

Gastroenterology Center of Connecticut P.C., Hamden

Cotton O'Neil Digestive Health Center, Topeka

Gastroenterology Research of New Orleans, Hammond

Gastroenterology Associates, Baton Rouge

Options Health Research, Tulsa

Digestive Health Specialists of Tyler, Tyler

Gastroenterology Clinic of San Antonio, San Antonio

Gastroenterology of the Rockies, Lafayette

The Oregon Clinic-West Hills Gastroenterology, Portland

University of Washington School of Medicine, Seattle

Massachusetts General Hospital Crohn's and Colitis Center, Boston

Dartmouth-Hitchcock Medical Center, Lebanon

Zeidler Ledcor Center-Univerisity of Alberta, Edmonton